The Company and its subsidiaries are principally engaged in (1) manufacture and sales of Chinese patent medicine; (2) wholesale, retail, import and export of western and Chinese pharmaceutical product >>>>>>
| 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019
Date Documents
02-05-2007 20:37 Reply Slip
02-05-2007 20:37 Proxy Form
02-05-2007 20:37 Circular (Notice of the 2006 annual general meeting)
14-02-2007 11:42 Reply Slip
14-02-2007 11:42 Proxy Form
14-02-2007 11:42 Reply Slip
14-02-2007 11:42 Proxy Form
14-02-2007 11:41 Reply Slip
14-02-2007 11:41 Proxy Form
14-02-2007 11:41 Circular (Major transaction: Disposal, deemed disposal and material dilution of equity interest in a major subsidiary)